Business Standard

Saturday, December 21, 2024 | 10:39 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Madras HC notice to Centre on plea to declare Serum's Covishield jab unsafe

Litigant is a Chennai-based consultant who volunteered for the trial. Claims he suffered side effects, for which he sought a compensation of Rs 5 cr

New Delhi: The first batch of Covishield vaccine reaches central storage facility at Rajiv Gandhi Super Specialty hospital in New Delhi, Tuesday, Jan. 12, 2021. (PTI Photo/ Kamal Kishore)
Premium

He claimed he filed the plea when his health condition worsened after taking Serum's vaccine

T E Narasimhan Chennai
The Madras High Court today issued a notice to the Centre on a petition to declare the Serum Institute's Covishield vaccine unsafe. 

The notice was issued in response to a writ petition filed by a Chennai-based business consultant who volunteered for the trial. He claims he suffered from side effects, for which he sought a compensation of Rs 5 crore.

Legal team representing the Serum Institute said, "Allegations made in the petition are unfounded and frivolous. Serum will respond to same appropriately before the madras high court."

In November 2020, the litigant sent a legal notice to Serum Institute

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in